Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1α-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers

Reproductive Sciences

Volumn 14, Issue 5, 2007, Pages 486-497

  Agic, Admir ^a   Xu, Hong ^a   Altgassen, Christopher ^a   Noack, Frank ^a   Wolfler, Monika M ^b   Diedrich, Klaus ^a   Friedrich, Michael ^a   Taylor, Robert N ^c   Hornung, Daniela ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometriosis; Gynecologic cancer; Hydroxylases; Vitamin D

Indexed keywords

1 ALPHA HYDROXYLASE; 25 HYDROXYLASE; 25 HYDROXYVITAMIN D; CALCITRIOL RECEPTOR; MESSENGER RNA; OXYGENASE; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG; CALCIDIOL 1 MONOOXYGENASE; CHOLESTANETRIOL 26 MONOOXYGENASE; STEROID MONOOXYGENASE; VITAMIN D 1 ALPHA HYDROXYLASE; VITAMIN D 1-ALPHA HYDROXYLASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PHYSIOLOGY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CELLS, CULTURED; CYTOCHROME P-450 CYP27A1; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES;

EID: 38449104619     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107304565     Document Type: Article

References (41)

1. Guyton KZ, Kensler TW, Posner GH Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev. 2003 ; 61: 227-238.
2. Ravid A., Koren R. The role of reactive oxygen species in the anticancer activity of vitamin D. Recent Results Cancer Res. 2003 ; 164: 357-367.
3. Koeffler HP, Aslanian N., O'Kelly J. Vitamin D (2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome. Leuk Res. 2005 ; 29: 1259-1262.
4. Holick MF Vitamin D: a millennium perspective. J Cell Biochem. 2003 ; 88: 296-307.
5. Zehnder D., Bland R., Hughes SV Analysis of the tissue distribution of 1α-hydroxylase identifies novel extra-renal sites for the synthesis of 1, 25-dihydroxyvitamin D3. J Endocrinol. 2000: 164 (suppl): P1.
6. Berger U., Wilson P., McClelland RA, Colston K., Haussler MR, Pike JW Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988 ; 67: 607-613.
7. Trump DL, Hershberger PA, Bernardi RJ, et al. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol. 2004 ; 89-90: 519-526.
8. Missmer SA, Cramer DW Epidemiology of endometriosis. In: Olive DL, ed. Endometriosis in Clinical Practice. London, UK: Taylor & Francis ; 2005: 49-60.
9. Varma R., Rollason T., Gupta JK, Maher ER Endometriosis and the neoplastic process. Reproduction. 2004 ;127: 293-304.
10. Donnez J., Squifflet J., Pirard C., Jadoul P., Wyns C., Smets M. The efficacy of medical and surgical treatment of endometriosis-associated infertility and pelvic pain. Gynecol Obstet Invest. 2002 ; 54 (suppl 1). 2-7.
11. Oral E., Ilvan S., Tustas E., et al. Prevalence of endometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol. 2003 ; 109: 97-101.
12. Malloy PJ, Feldman D. Vitamin D resistance. Am J Med. 1999 ; 106: 355-370.
13. Hewison M., Zehnder D., Bland R., Stewart PM 1alpha-hydroxylase and the action of vitamin D. J Mol Endocrinol. 2000 ; 25: 141-148.
14. Haussler M., Mangelsdorf DJ, Komm BS, et al. Molecular biology of the vitamin D hormone. Recent Prog Horm Research. 1988 ; 44: 263-305.
15. Mangelsdorf DJ, Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell. 1995 ; 83: 835-839.
16. Kliewer SA, Umesono K., Mangelsdorf DJ, Evans RM Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 ; 355: 446-449.
17. Jones G., Strugnell SA, DeLuca HF Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998 ; 78: 1193-1231.
18. Porojnicu AC, Robsahm TE, Dahlback A., et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role? Lung Cancer. 2007 ; 55: 263-270.
19. Yabushita H., Hirata M., Noguchi M., Nakanishi M. Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1, 25-dihydroxyvitamin D3 on endometrial carcinoma cell lines. J Obstet Gynaecol Res. 1996 ; 22: 529-539.
20. Cross HS, Bises G., Lechner D., Manhardt T., Kallay E. The Vitamin D endocrine system of the gut-its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol. 2005 ; 97: 121-128.
21. Villena-Heinsen C., Meyberg R., Axt-Fliedner R., Reitnauer K., Reichrath J., Friedrich M. Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3- receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res. 2002 ; 22: 2261-2267.
22. Saunders DE, Christensen C., Lawrence WD, et al. Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms. Gynecol Oncol. 1992 ; 44: 131-136.
23. Friedrich M., Rafi L., Mitschele T., Tilgen W., Schmidt W., Reichrath J. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003 ; 164: 239-246.
24. Ahonen MH, Zhuang YH, Aine R., Ylikomi T., Tuohimaa P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer. 2000 ; 86: 40-46.
25. Anderson MG, Nakane M., Ruan X., Kroeger P., Wu-Wong JR Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 2006 ; 57: 234-240.
26. Feng J., Junying B., Pengfei L., Santo VN, Wenlong B. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem. 2004 ; 279: 53213-53221.
27. Pengfei L., Chunrong L., Xiuhua Z., Xiaohong Z., Santo VN, Wenlong B. p27Kip1 stabilization and G1 arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through down-regulation of cyclin e/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/skp2 ubiquitin ligase. J Biol Chem. 2004 ; 279: 25260-25267.
28. Armitage EL, Aldhous MC, Anderson N., et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004 ; 127: 1051-1057.
29. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MC incidence in two prospective studies of US women. Neurology. 1999 ; 51: 1711-1718.
30. Rostand SG Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1979 ; 30: 150-156.
31. Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989 ; 1: 1176-1178.
32. Garland FC, Garland CF, Gorham ED, Young JF Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990 ; 19: 614-622.
33. Ahonen MH, Tenkanen L., Teppo L., Hakama M., Tuohimaa P. Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000 ; 11: 847-852.
34. Ferrero S., Gillott DJ, Anserini P., et al. Vitamin D binding protein in endometriosis. J Soc Gynecol Investig. 2005 ; 12: 272-277.
35. Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D. Oxidative stress and endometriosis. Hum Reprod. 2005 ; 20: 2014-2020.
36. Agarwal A., Gupta S., Sharma RK Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005 ; 3: 28.
37. Vienonen A., Miettinen S., Blauer M., et al. Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig. 2004 ; 11: 61-62.
38. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig. 2004 ; 11: 263-271.
39. Vigano P., Lattuada D., Mangioni S., et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol. 2006 ; 36: 415-424.
40. Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab. 2005 ; 90: 4803-4808.
41. Agic A., Xu H., Finas D., Banz C., Diedrich K., Hornung D. Is endometriosis associated with systemic sublinical inflammation? Gynecol Obstet Invest. 2006 ; 62: 139-147.